Literature DB >> 16972187

Local recurrence and distant metastasis of supratentorial primitive neuro-ectodermal tumor in an adult patient successfully treated with intensive induction chemotherapy and maintenance temozolomide.

F Terheggen1, D Troost, C B Majoie, S Leenstra, D J Richel.   

Abstract

Supratentorial primitive neuro-ectodermal tumors (PNET) in adults are very rare. Extraneural metastasis are unusual and the optimal palliative chemotherapy regimen is not established. We present a 26-year-old patient with local recurrence and distant metastasis of supratentorial PNET successfully treated with intensive induction chemotherapy and maintenance temozolomide.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16972187     DOI： 10.1007/s11060-006-9249-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  16 in total

1.  High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

Authors:  Antonio Pérez-Martínez; Alvaro Lassaletta; Marta González-Vicent; Julián Sevilla; Miguel Angel Díaz; Luis Madero
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience.

Authors:  A C Paulino; E Melian
Journal:  Cancer       Date:  1999-07-01       Impact factor: 6.860

Review 3.  Medulloblastoma in adults: clinical characteristics and treatment.

Authors:  A A Brandes; V Palmisano; S Monfardini
Journal:  Cancer Treat Rev       Date:  1999-02       Impact factor: 12.111

4.  Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.

Authors:  R T Woodburn; B Azzarelli; J F Montebello; I E Goss
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 5.  Current and future developments in the use of temozolomide for the treatment of brain tumours.

Authors:  R Stupp; M Gander; S Leyvraz; E Newlands
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

6.  A clinicobiological model predicting survival in medulloblastoma.

Authors:  Amit Ray; Michael Ho; Jing Ma; Robert K Parkes; Todd G Mainprize; Shigeo Ueda; John McLaughlin; Eric Bouffet; James T Rutka; Cynthia E Hawkins
Journal:  Clin Cancer Res       Date:  2004-11-15       Impact factor: 12.531

Review 7.  Primitive neuroectodermal tumour in a 60-year-old man: a case report and literature review.

Authors:  M J Balafouta; J R Kouvaris; A C Miliadou; X N Papacharalampous; D V Kolokouris; V E Kouloulias; A D Mariolis; L J Vlahos
Journal:  Br J Radiol       Date:  2003-01       Impact factor: 3.039

Review 8.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

9.  PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Derya Gümürdühü; Handan Zeren; Tahsin Erman
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

10.  Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.

Authors:  C Soussain; C Patte; M Ostronoff; A Delmer; F Rigal-Huguet; N Cambier; P Y Leprisé; S François; P Cony-Makhoul; J L Harousseau
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113
View more
  2 in total

1.  Therapeutic Difficulty in a Case of Supratentorial Primitive Neuroectodermal Tumor Diagnosed during Pregnancy.

Authors:  Feyzi Birol Sarica; Kadir Tufan; Orhan Sen; Bulent Erdogan
Journal:  J Korean Neurosurg Soc       Date:  2009-01-31

2.  A supratentorial primitive neuroectodermal tumor presenting with intracranial hemorrhage in a 42-year-old man: a case report and review of the literature.

Authors:  Evangelos K Papadopoulos; Kostas N Fountas; Alexandros G Brotis; Konstantinos N Paterakis
Journal:  J Med Case Rep       Date:  2013-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.